Mustang Bio
MBIO
MBIO
79 hedge funds and large institutions have $71.8M invested in Mustang Bio in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $85.7M → $71.8M (-$13.9M)
63% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 19
Holders
79
Holding in Top 10
–
Calls
$1.19M
Puts
$685K
Top Buyers
| 1 | +$1.27M | |
| 2 | +$1.19M | |
| 3 | +$1.12M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$867K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$813K |
Top Sellers
| 1 | -$1.12M | |
| 2 | -$1.06M | |
| 3 | -$527K | |
| 4 |
VF
Virtu Financial
New York
|
-$389K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$350K |